ASIA unversity:Item 310904400/16391
English  |  正體中文  |  简体中文  |  全文笔数/总笔数 : 90096/105238 (86%)
造访人次 : 7183164      在线人数 : 630
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜寻范围 查询小技巧:
  • 您可在西文检索词汇前后加上"双引号",以获取较精准的检索结果
  • 若欲以作者姓名搜寻,建议至进阶搜寻限定作者字段,可获得较完整数据
  • 进阶搜寻


    jsp.display-item.identifier=請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/16391


    题名: Curcumin Inhibits Human Lung Large Cell Carcinoma Cancer Tumour Growth in a Murine Xenograft Model
    作者: ;Su, Chin-Cheng;楊家欣;Yang, Jai-Sing;呂啟誠;Lu, Chi-Cheng;江若華;Chiang, Jo-Hua;吳長霖;Wu, Chang-Lin;Lin, Jen-Jyh;賴光啟;Lai, Kuang-Chi;夏德椿;Hsia, Te-Chun;呂旭峰;Lu, Hsu-Feng;范宗宸;Fan, Ming-Jen;鍾景光;Chung, Jing-gung
    贡献者: 生物科技學系
    日期: 2010-01
    上传时间: 2012-11-23 17:12:27 (UTC+8)
    摘要: Curcumin can decrease viable cells through the induction of apoptosis in human lung cancer NCI-H460 cells in vitro. However, there are no reports that curcumin can inhibit cancer cells in vivo. In this study, NCI-H460 lung tumour cells were implanted directly into nude mice and divided randomly into four groups to be treated with vehicle, curcumin (30 mg/kg of body weight), curcumin (45 mg/kg of body weight) and doxorubicin (8 mg/kg of body weight). Each agent was injected once every 4 days intraperitoneally (i.p.), with treatment starting 4 weeks after inoculation with the NCI-H460 cells. Treatment with 30 mg/kg and 45 mg/kg of curcumin or with 8 mg/kg of doxorubicin resulted in a reduction in tumour incidence, size and weight compared with the control group. The findings indicate that curcumin can inhibit tumour growth in a NCI-H460 xenograft animal model in vivo.
    關聯: PHYTOTHERAPY RESEARCH;Volume(24):189–192
    显示于类别:[生物科技學系] 期刊論文

    文件中的档案:

    档案 描述 大小格式浏览次数
    index.html0KbHTML100检视/开启


    在ASIAIR中所有的数据项都受到原著作权保护.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回馈